Blank SV - Search Results

1

A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer.

Stein SM, Tiersten A, Hochster HS, Blank SV, Pothuri B, Curtin J, Shapira I, Levinson B, Ivy P, Joseph B, Guddati AK, Muggia F. Stein SM, et al. Among authors: blank sv. Int J Gynecol Cancer. 2013 Nov;23(9):1577-82. doi: 10.1097/IGC.0b013e3182a809e0. Int J Gynecol Cancer. 2013. PMID: 24172094 Free PMC article. Clinical Trial.

2

Epidermal growth factor receptor inhibitors for the treatment of epithelial ovarian cancer.

Blank SV, Chang R, Muggia F. Blank SV, et al. Oncology (Williston Park). 2005 Apr;19(4):553-9; discussion 560-2, 567. Oncology (Williston Park). 2005. PMID: 15934521 Free article. Review.

3

More than a name.

Blank SV, Curtin JP. Blank SV, et al. J Clin Oncol. 2007 Aug 10;25(23):3551; author reply 3557-8. doi: 10.1200/JCO.2007.12.2911. J Clin Oncol. 2007. PMID: 17687163 No abstract available.

4

Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study.

Addeo D, Blank S, Muggia F, Formenti S. Addeo D, et al. Anticancer Res. 2008 Sep-Oct;28(5B):3143-6. Anticancer Res. 2008. PMID: 19031972 Free article. Clinical Trial.

5

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.

Kuo DY, Blank SV, Christos PJ, Kim M, Caputo TA, Pothuri B, Hershman D, Goldman N, Ivy PS, Runowicz CD, Muggia F, Goldberg GL, Einstein MH. Kuo DY, et al. Among authors: blank sv. Gynecol Oncol. 2010 Mar;116(3):442-6. doi: 10.1016/j.ygyno.2009.10.082. Epub 2009 Nov 20. Gynecol Oncol. 2010. PMID: 19931137 Free PMC article. Clinical Trial.

6

Lymph node dissection in the surgical management of atypical endometrial hyperplasia.

Whyte JS, Gurney EP, Curtin JP, Blank SV. Whyte JS, et al. Among authors: blank sv. Am J Obstet Gynecol. 2010 Feb;202(2):176.e1-4. doi: 10.1016/j.ajog.2009.10.855. Epub 2009 Dec 21. Am J Obstet Gynecol. 2010. PMID: 20022313

7

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment.

Blank SV, Christos P, Curtin JP, Goldman N, Runowicz CD, Sparano JA, Liebes L, Chen HX, Muggia FM. Blank SV, et al. Gynecol Oncol. 2010 Dec;119(3):451-6. doi: 10.1016/j.ygyno.2010.08.008. Epub 2010 Sep 15. Gynecol Oncol. 2010. PMID: 20837357 Free PMC article. Clinical Trial.

8

Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer.

Safra T, Andreopoulou E, Levinson B, Borgato L, Pothuri B, Blank S, Tiersten A, Boyd L, Curtin J, Muggia F. Safra T, et al. Anticancer Res. 2010 Sep;30(9):3243-7. Anticancer Res. 2010. PMID: 20944093 Clinical Trial.

9

Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer.

Andreopoulou E, Chen T, Liebes L, Curtin J, Blank S, Wallach R, Hochster H, Muggia F. Andreopoulou E, et al. Cancer Chemother Pharmacol. 2011 Aug;68(2):457-63. doi: 10.1007/s00280-010-1510-y. Epub 2010 Nov 11. Cancer Chemother Pharmacol. 2011. PMID: 21069334 Clinical Trial.

10

Targeting the mTOR/4E-BP pathway in endometrial cancer.

Korets SB, Czok S, Blank SV, Curtin JP, Schneider RJ. Korets SB, et al. Among authors: blank sv. Clin Cancer Res. 2011 Dec 15;17(24):7518-28. doi: 10.1158/1078-0432.CCR-11-1664. Epub 2011 Dec 5. Clin Cancer Res. 2011. PMID: 22142830 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters